Thiazolyl dihydro-indazoles

Details for Australian Patent Application No. 2007233728 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Betzemeier, Bodo; Gerstberger, Thomas; Hoffmann, Matthias; Van Der Veen, Lars; Impagnatiello, Maria; Weyer-Czernilofsky, Ulrike; Mcconnell, Darryl; Steurer, Steffen; Grauert, Matthias

Agent Davies Collison Cave

Pub. Number AU-A-2007233728

PCT Pub. Number WO2007/113245

Priority 06112303.0 06.04.06 EP

Filing date 30 March 2007

Wipo publication date 11 October 2007

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/113245 Priority application(s): WO2007/113245

25 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007233729-Thiazolyldihydroindazole derivatives as protein kinase inhibitors

2007233715-Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine D3 receptors